Table 2.
Pre | Post | P-value | |
---|---|---|---|
FG (mmol/L) | 5.08 (4.76–5.60) | 4.97 (4.76–5.66) | 0.614 |
FINS (μU/mL) | 15.60 (13.45–25.00) | 12.30 (10.30–17.30) | 0.017* |
AUCIns (mU/L*min) | 15,974 ± 6158 | 11,694 ± 5230 | 0.007* |
AUCGlu (mmol/L*min) | 963.8 ± 140.9 | 988.3 ± 190.7 | 0.516 |
AUCIns/AUCGlu | 16.49 ± 5.90 | 11.84 ± 4.80 | 0.001* |
HOMA-IR | 3.45 (2.91–5.64) | 2.73 (2.27–3.85) | 0.025* |
TG (mmol/L) | 1.23 (0.94–1.68) | 1.05 (0.70–1.67) | 0.715 |
TC (mmol/L) | 4.57 ± 0.75 | 4.43 ± 0.66 | 0.328 |
LDL-C (mmol/L) | 2.76 ± 0.61 | 2.75 ± 0.62 | 0.984 |
FG: Fasting glucose; FINS: fasting insulin; AUCIns: area under the curve (AUC) for insulin; AUCGlu: area under the curve (AUC) for glucose; HOMA-IR: homeostasis model assessment-insulin resistance; TG: triglycerides; TC: total cholesterol; LDL-C: low density lipoprotein-cholesterol
The comparison across timepoints has been assessed using Paired t test and Wilcoxon test
Results are expressed as mean ± SD or median (25th–75th percentile)
*P < 0.05